Editorial

About DigiDiag

DigiDiag is a 5-year program started in the summer of 2012, funded by the French Investissement d’Avenir program.

DigiDiag aims to develop miniaturized micro/nanofluidic lab on a chip systems for point-of-care (and other) applications in diagnostics, clinical management and personalized medicine. We aim to mature technologies to the point at which they can be successfully commercialised.

The project is highly multidisciplinary and, in order to achieve our goal, the consortium regroups 13 partners with expertise ranging through micro/nanofabrication, micro/nanofluidics, chemistry, physicochemistry, biochemistry, molecular biology, cell biology, instrumentation and clinical medicine, located throughout France (Ile de France, Toulouse and Bordeaux).